Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

DOI Web Site Web Site 被引用文献2件

収録刊行物

  • The Lancet

    The Lancet 399 (10333), 1383-1390, 2022-04

    Elsevier BV

被引用文献 (2)*注記

もっと見る

問題の指摘

ページトップへ